Global Radiation Therapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global radiation therapy market is segmented by type, procedure, technology, and end use, each contributing to the growth and evolution of the industry. The primary types of radiation therapy include external beam radiation therapy (EBRT), internal beam radiation therapy (IBRT), and systemic radiation therapy, with EBRT leading the market. EBRT, which involves directing radiation from outside the body, is widely used due to its effectiveness in treating a variety of cancers. It encompasses advanced techniques such as stereotactic radiosurgery and intensity-modulated radiation therapy (IMRT), providing high precision and minimizing exposure to healthy tissues. IBRT, or brachytherapy, remains popular for treating cancers like prostate and cervical cancer due to its targeted approach, while systemic radiation therapy, typically used for thyroid cancer, continues to expand with advancements in radiopharmaceuticals.

In terms of procedure, the market is divided into IGRT, IMRT, 3D-CRT, HDR, LDR, and PDR. Image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) are the most prominent due to their precision in treating tumors while minimizing damage to surrounding healthy tissue. IGRT’s real-time imaging capabilities make it essential for tumors that move, such as those in the lung or prostate. IMRT offers flexibility in tumor treatment, providing a more targeted approach, particularly for cancers in the head, neck, and prostate. Other procedures like 3D conformal radiation therapy (3D-CRT) and brachytherapy cater to specific cancers and treatment requirements, with brachytherapy being a particularly effective localized treatment for several cancers.

The technology segment includes advanced options like MR LINAC, stereotactic therapy, particle therapy, IBRT/brachytherapy, and cobalt-60 teletherapy. MR LINAC, combining magnetic resonance imaging with radiation delivery, is gaining traction due to its precision and the ability to track tumors in real-time, making it ideal for complex cancers. Stereotactic therapy, including stereotactic radiosurgery and body radiation therapy, remains crucial in treating small, well-defined tumors with minimal damage to surrounding tissues. Particle therapy, though still emerging, holds great promise for treating difficult-to-reach tumors, and brachytherapy remains a key method in localized treatment. Cobalt-60 teletherapy, while less common in high-income countries, remains a vital solution in resource-constrained settings.

The end-use segment of the market includes hospitals, diagnostic centers, research laboratories, and specialty clinics, with hospitals being the dominant user of radiation therapy equipment. Hospitals treat a high volume of cancer patients, requiring various radiation therapy technologies across multiple specialties. Diagnostic centers are increasingly adopting radiation therapy, particularly in regions with outpatient services. Research laboratories play a crucial role in advancing radiation therapy techniques, while specialty clinics focus on treating specific cancer types, such as prostate or breast cancer, using tailored radiation therapies. As the demand for cancer treatment continues to grow, the adoption of radiation therapy across these end-use sectors is expected to expand further, driven by technological advancements and a broader push for precision medicine.

Global Radiation Therapy Segment Analysis

In this report, the global radiation therapy market has been segmented by type, Procedure, Technology, end use and geography.

Global Radiation Therapy Market, Segmentation by Type

The Global Radiation Therapy Market has been segmented by Type into External-beam Radiation Therapy - Conformal Radiation Therapy, Proton beam Therapy, Image-guided Radiation Therapy, Stereotactic Radiation Therapy and Others, Internal Radiation Therapy - Brachytherapy and Systemic Radiation Therapy.

The Global Radiation Therapy Market has been segmented by type into External-beam Radiation Therapy and Internal Radiation Therapy, each offering distinct approaches to cancer treatment. External-beam Radiation Therapy involves directing high-energy radiation from a machine outside the body to target cancer cells. This method is commonly used for treating solid tumors, such as those in the prostate, lung, and breast. It allows for precise targeting of tumors while minimizing damage to surrounding healthy tissues, thereby reducing side effects. Technological advancements in external-beam radiation therapy, such as image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT), have further improved treatment outcomes and patient experience.

On the other hand, Internal Radiation Therapy, also known as brachytherapy, involves placing radioactive sources directly into or near the tumor site within the body. This approach allows for the delivery of high doses of radiation to the tumor while sparing nearby healthy tissues. Internal Radiation Therapy is often used for treating localized cancers, such as cervical, prostate, and gynecological cancers. It offers advantages such as shorter treatment durations and reduced radiation exposure to surrounding tissues compared to external-beam radiation therapy.

The segmentation of the global radiation therapy market into External-beam Radiation Therapy and Internal Radiation Therapy reflects the diversity and versatility of treatment options available to patients and healthcare providers. Both approaches play critical roles in cancer management, offering targeted and effective treatments tailored to individual patient needs. As technology continues to advance and treatment techniques evolve, the integration of external-beam and internal radiation therapy modalities is likely to further optimize cancer care, improving outcomes and enhancing the quality of life for cancer patients worldwide.

Global Radiation Therapy Market, Segmentation by Procedure

The Global Radiation Therapy Market has been segmented by Procedure into IGRT, IMRT, 3D-CRT, HDR, LDR, and PDR.

Image-guided radiation therapy (IGRT) holds a prominent share due to its precision and real-time imaging capabilities, allowing clinicians to track tumor movements and adjust treatment accordingly. IGRT’s effectiveness in minimizing radiation exposure to surrounding healthy tissues makes it a preferred choice in cases where tumors are located near critical structures or organs.

Intensity-modulated radiation therapy (IMRT) is another widely adopted procedure, known for its ability to deliver highly precise radiation doses to irregularly shaped tumors. IMRT is particularly favored in treating cancers of the head, neck, and prostate, where precision is critical. Its growing adoption is supported by technological advancements and its ability to improve patient outcomes through targeted dose escalation while reducing side effects.

Three-dimensional conformal radiation therapy (3D-CRT) remains a standard option, offering a balance of efficacy and accessibility. This procedure leverages three-dimensional imaging to shape radiation beams to the tumor, reducing exposure to healthy tissues. While newer techniques like IGRT and IMRT are gaining traction, 3D-CRT continues to be widely used in regions with limited access to advanced technologies due to its cost-effectiveness and reliability.

High-dose rate (HDR), low-dose rate (LDR), and pulsed-dose rate (PDR) brachytherapy represent key segments in internal radiation therapy. HDR brachytherapy is gaining popularity for its shorter treatment times and ability to deliver high radiation doses directly to the tumor. LDR brachytherapy, often used in prostate cancer treatment, involves continuous low-dose radiation over extended periods. PDR combines aspects of both HDR and LDR, offering a balance of precision and patient comfort. These procedures cater to specific cancer types and stages, underscoring their importance in the overall radiation therapy landscape.

Global Radiation Therapy Market, Segmentation by Technology

The Global Radiation Therapy Market has been segmented by Technology into EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, and Cobalt-60 Teletherapy.

External beam radiation therapy (EBRT) using MR LINAC (Magnetic Resonance Linear Accelerator) is one of the most advanced technologies in the market. It combines magnetic resonance imaging (MRI) with a linear accelerator to provide real-time tumor visualization and precise targeting, allowing for more accurate treatment delivery and minimizing damage to surrounding healthy tissue. The growing adoption of MR LINAC is driven by its enhanced imaging capabilities, offering greater precision and improving patient outcomes.

Stereotactic radiation therapy, including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT), is another prominent technology in the market. This method uses focused beams of radiation to treat small, well-defined tumors with high precision, often in cases where traditional surgery may not be feasible. Stereotactic techniques are particularly effective for brain, lung, and spinal cancers, and their ability to treat tumors with minimal damage to surrounding tissues makes them a preferred choice for many healthcare providers.

Particle therapy, including proton therapy and heavy ion therapy, is increasingly gaining recognition for its precision and ability to treat difficult-to-reach or inoperable tumors. Unlike conventional X-rays, particle therapy uses charged particles to deliver radiation, allowing for a higher dose of radiation to be delivered directly to the tumor while minimizing exposure to surrounding healthy tissues. This technology is particularly useful in pediatric oncology and in treating tumors near critical organs, but its high cost and limited availability continue to restrict widespread use.

Internal beam radiation therapy (IBRT) or brachytherapy is a technology where a radioactive source is placed directly inside or very close to the tumor. This method is commonly used for prostate, cervical, and breast cancers. Brachytherapy allows for a high dose of radiation to be delivered precisely to the tumor while sparing healthy surrounding tissue. Its ability to provide localized treatment has made it a popular option for several cancer types, particularly in cases where external beam radiation is less effective.

Cobalt-60 teletherapy, although less common today, remains a relevant technology, particularly in low-resource settings. It utilizes cobalt-60, a radioactive isotope, to deliver external beam radiation therapy. While newer technologies like MR LINAC and particle therapy are gaining ground, cobalt-60 teletherapy continues to provide an affordable and effective treatment option in many parts of the world, particularly for patients in regions with limited access to advanced equipment.

Global Radiation Therapy Market, Segmentation by End Use

The Global Radiation Therapy Market has been segmented by End Use into Hospitals, Specialty Clinics and Others.

The global radiation therapy market is segmented by end use into hospitals, specialty clinics, and others. Hospitals currently dominate the market due to their advanced infrastructure, comprehensive cancer care facilities, and high patient footfall. Hospitals serve as primary centers for cancer diagnosis, treatment, and follow-up care, making them key contributors to the demand for radiation therapy equipment and services. Additionally, the availability of skilled healthcare professionals, including radiation oncologists, medical physicists, and radiation therapists, further bolsters the prominence of hospitals in the radiation therapy landscape.

Specialty clinics represent another significant segment in the global radiation therapy market. These clinics specialize in providing cancer care services, including radiation therapy, and often offer personalized treatment plans tailored to individual patient needs. Specialty clinics are preferred by some patients for their focused expertise, shorter wait times, and more personalized care experience compared to larger hospital settings. Moreover, advancements in technology have enabled the establishment of specialized radiation therapy centers that offer state-of-the-art equipment and innovative treatment modalities, attracting patients seeking cutting-edge cancer care solutions.

Other end-use segments in the global radiation therapy market include ambulatory surgical centers, cancer research institutes, and academic medical centers, among others. While these segments may have a smaller market share compared to hospitals and specialty clinics, they play a vital role in the overall ecosystem of cancer care and research. Ambulatory surgical centers provide outpatient radiation therapy services, offering convenience and cost-effectiveness for patients requiring short treatment courses. Cancer research institutes and academic medical centers contribute to advancing the field of radiation oncology through research, clinical trials, and education, driving innovation and shaping the future of cancer treatment paradigms.

Global Radiation Therapy Market, Segmentation by Geography

In this report, the Global Radiation Therapy Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Radiation Therapy Market Share (%), by Geographical Region, 2024

The global radiation therapy market share is distributed across various geographical regions, with North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa being the key players. North America holds the largest share due to its advanced healthcare infrastructure, high adoption rates of innovative technologies, and substantial investments in cancer research and treatment. The United States, in particular, dominates this region with its significant contribution to market growth, driven by the prevalence of cancer and favorable reimbursement policies. Europe follows closely, with countries like Germany, the UK, and France being key contributors, owing to their well-established healthcare systems and increasing awareness about cancer treatment options.

In the Asia-Pacific region, market growth is fueled by factors such as rising healthcare expenditure, improving healthcare infrastructure, and increasing prevalence of cancer in countries like China, India, and Japan. Moreover, initiatives by governments and private organizations to enhance cancer care facilities and promote early detection and treatment are driving market expansion in this region. Latin America and the Middle East and Africa regions also show promising growth opportunities, albeit with relatively smaller market shares. These regions are witnessing increasing investments in healthcare infrastructure and rising awareness about cancer treatment options, which are expected to contribute to market growth in the coming years. Overall, the global radiation therapy market is characterized by a diverse geographical landscape, with each region presenting unique opportunities and challenges for market players.

This report provides an in depth analysis of various factors that impact the dynamics of Global Radiation Therapy Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Key players in Global Radiation Therapy Market include:

• Varian Medical Systems, Inc.
• Elekta AB
• Accuray Incorporated
• Siemens Healthineers
• ViewRay, Inc.
• IBA Worldwide
• ProTom International, Inc.
• Mevion Medical Systems, Inc.
• RaySearch Laboratories AB
• Hitachi, Ltd.

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis